Business
Johnson & Johnson COVID-19 vaccine under review by European Medicines Agency over blood clots – ABC News
Europe’s drug regulator says it is reviewing rare blood clots in four people in the United States who received Johnson & Johnson’s COVID-19 vaccine.
Europes drug regulator says it is reviewing rare blood clots in four people in the United States who received Johnson & Johnsons COVID-19 vaccine.
Key points:
- Johnson & Johnson said it was aware of the rare reports of blood clots, and was working with regulators to assess the data
- The US Food and Drug Administration said it was aware of the reports, but they had “not found a causal relationship with vaccination”
- It follows an investigation of blood clots reported by some people given the AstraZeneca…
Continue Reading
-
Noosa News22 hours agoMan shot by police outside Wynnum West house fire charged with attempted murder and arson
-
Noosa News19 hours agoBrisbane man charged with arson and attempted murder after violent house fire at Wynnum West
-
Business23 hours agoGuess which dirt cheap ASX 200 stock could rise 50%+
-
Business22 hours agoWhy these brokers are very bullish on this ASX bank share